Food News and Research

RSS

New findings link obesity and dietary factors to late-life dementias

Difficulties learning, remembering, and concentrating. An inability to resist environmental temptations to eat. A lifetime of progressive deterioration in the brain.

9 Oct 2014

European experts publish common vision of priorities for marine research

Some 340 European scientists, policy-makers and other experts representing 143 organizations from 31 countries spoke with one voice today, publishing a common vision of today's most pressing marine-related health and economic threats and opportunities.

9 Oct 2014

DiabeticWatchers launches web-based app to create awareness, prevention of diabetes

DiabeticWatchers announced today the official launch of DiabeticWatchers.com, a web based and mobile application devoted to creating awareness and prevention of diabetes, through community outreach campaigns, and offering cutting edge technology to help those living with diabetes to manage the disease.

9 Oct 2014

Women may halve their stroke risk through healthy living, new study shows

Women who follow a healthy lifestyle may be cutting their risk of stroke by more than 50%, report Swedish researchers.

9 Oct 2014

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG. Under the term loan agreement, CRG will provide up to $30 million to support the commercialization of the NephroCheck Test System.

9 Oct 2014

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.

9 Oct 2014

RPS Diagnostics receives CE mark for FebriDx test

RPS Diagnostics, Inc. today announced CE mark of its FebriDx test, clearing the way for sales in the European Union and all countries recognizing the CE mark.

9 Oct 2014

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Impax Laboratories, Inc. today announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, Inc., including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage Therapeutics Inc. (together, the "Companies") for $700 million in cash, subject to certain customary purchase price adjustments.

9 Oct 2014

Study finds that skin exposure may trigger early peanut allergy in children

Many children may become allergic to peanuts before they first eat them, and skin exposure may be contribute to early sensitization, according to a study in mice led by Mount Sinai researchers and published today in the Journal of Clinical Investigation.

9 Oct 2014

Social status can impact health, happiness even among egalitarian forager-farmers

In western society, where keeping up with the Joneses — or, better yet, surpassing them — is expected and even encouraged, status matters. So important is it that for many people, physical and emotional wellbeing are directly connected to their place in the social hierarchy.

9 Oct 2014

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

9 Oct 2014

Women with healthy diet and lifestyle less likely to have stroke

Women with a healthy diet and lifestyle may be less likely to have a stroke by more than half, according to a study published in the October 8, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Oct 2014

Specific perceptual learning deficit associated with Fragile X Syndrome

Researchers at Children's Hospital Los Angeles have described for the first time a specific perceptual learning deficit in mice with a mutation of the same gene as found in children with Fragile X Syndrome (FXS).

9 Oct 2014

Temple researchers to create awareness about healthy diet among low-income Asian Americans

Although low-income Asian Americans are at a high risk for diabetes, hypertension, heart attack and stroke, they are under a misconception that their diet is healthy and not a risk factor for these chronic diseases.

9 Oct 2014

CHOP joins CEGIR to advance treatment of eosinophilic disorders

The Children's Hospital of Philadelphia has joined a new consortium announced today by the National Institutes of Health to advance the treatment of chronic inflammatory diseases called eosinophilic disorders.

9 Oct 2014

CSL Behring strengthens global manufacturing capabilities to meet demand for lifesaving therapies

CSL Behring today announced a multi-year, $450 million two-site global capacity expansion – the latest in a series of recent production expansions to meet the growing need for its lifesaving and life-improving therapies that are used to treat patients with rare and serious medical disorders around the world.

8 Oct 2014

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3 isavuconazole VITAL study being presented at IDWeek on October 10, 2014, in Philadelphia, Pa.

8 Oct 2014

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.

8 Oct 2014

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).

8 Oct 2014

Menu items containing 12% fewer calories could have significant impact on obesity epidemic

New research from the Johns Hopkins Bloomberg School of Public Health finds that large chain restaurants, whose core menu offerings are generally high in calories, fat and sodium, introduced newer food and beverage options that, on average, contain 60 fewer calories than their traditional menu selections in 2012 and 2013.

8 Oct 2014

Food News and Research

New findings link obesity and dietary factors to late-life dementias

European experts publish common vision of priorities for marine research

DiabeticWatchers launches web-based app to create awareness, prevention of diabetes

Women may halve their stroke risk through healthy living, new study shows

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

RPS Diagnostics receives CE mark for FebriDx test

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Study finds that skin exposure may trigger early peanut allergy in children

Social status can impact health, happiness even among egalitarian forager-farmers

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Women with healthy diet and lifestyle less likely to have stroke

Specific perceptual learning deficit associated with Fragile X Syndrome

Temple researchers to create awareness about healthy diet among low-income Asian Americans

CHOP joins CEGIR to advance treatment of eosinophilic disorders

CSL Behring strengthens global manufacturing capabilities to meet demand for lifesaving therapies

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Menu items containing 12% fewer calories could have significant impact on obesity epidemic

Understanding cultivated meat and its global potential eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News